Eli Lilly, Elan Get $8M In Fees After Alzheimer's IP Win

Law360, Los Angeles (April 18, 2016, 10:53 PM EDT) -- A California federal judge on Friday ordered the Alzheimer's Institute of America to pay Eli Lilly and Elan Pharmaceuticals roughly $8 million in attorneys' fees after losing a suit backed by an “ego and greed” driven scheme to misrepresent the true owner of a patent covering Alzheimer's detection.

U.S. District Judge Elizabeth D. LaPorte's ruling awarded Eli Lilly & Co. $4,445,492 and Elan Pharmaceuticals Inc. $3,435,130 for their work successfully defending the patent infringement suit. The ruling solely concerned the amount of attorneys' fees AIA would...
To view the full article, register now.